Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007)

Medecine et Maladies Infectieuses

Volumn 40, Issue 2, 2010, Pages 74-80

  Thibaut, S ^a   Caillon, J ^a,b   Huart, C ^a   Grandjean, G ^a   Lombrail, P ^a,c   Potel, G ^a,b   Ballereau, F ^a,b,c  

^a CHU DE NANTES   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic resistance; Community ecology; Escherichia coli; MRSA; Staphylococcus aureus

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; METICILLIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISK DIFFUSION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FRANCE; GENITAL SYSTEM; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; URINALYSIS; COMMUNICABLE DISEASE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77949333745     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.01.011     Document Type: Article

References (26)

1. Arpin C., Coulange L., Dubois V., André C., Fischer I., Fourmaux S., et al. Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers. Antimicrob Agents Chemother 51 9 (2007) 3440-3444
2. Arpin C., Dubois V., Maugein J., Jullin J., Dutilh B., Brochet J.P., et al. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting. J Clin Microbiol 43 10 (2005) 5048-5054
3. Quentin C., Arpin C., Dubois V., André C., Lagrange I., Fischer I., et al. Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extrahospital practice. Eur J Clin Microbiol Infect Dis 23 3 (2004) 185-193
4. Arpin C., Dubois V., Coulange L., André C., Fischer I., Noury P., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47 11 (2003) 3506-3514
5. http://www.onerba.org
6. Shorr A.F. Epidemiology of staphylococcal resistance. Clin Infect Dis 45 Suppl. 3 (2007) S171-S176
7. http://www.sfm.asso.fr
8. De Mouy D., Cavallo J.D., Armengaud M., Arzouni J.P., Berges J.L., Bouilloux J.P., et al. Urinary tract infection in an urban population: etiology and antibiotic sensitivity as a function of patient history. Presse Med 28 30 (1999) 1624-1628
9. Goldstein F.W., Péan Y., Gertner J., and the Vigil'roc study group. Resistance to Ceftriaxone and other β-Lactams in bacteria isolated in the community. Antimicrob Agents Chemother 39 11 (1995) 2516-2519
10. Goldstein F.W., and the Multicentre Study Group. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis 19 2 (2000) 112-117
11. de Mouy D., Fabre R., Cavallo J.D., Arzouni J.P., Baynat M., Bicart-See A., et al. Community-acquired urinary tract infections in 15 to 65 years old female patients in France. Susceptibility of Escherichia coli according to history: AFORCOPI-BIO network 2003. Med Mal Infect 37 (2007) 594-598
12. Garau J., Xercavins M., Rodriguez-Carballeira M., Gomez-Vera J.R., Coll I., Vidal D., et al. Emergence and dissemination of Quinolone-Resistant Escherichia coli in the community. Antimicrob Agents Chemother 43 (1999) 2736-2741
13. Cizman M., Orazem A., Krizan-Hergouth V., and Kolman J. Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections. J Antimicrob Chemother 47 (2001) 502
14. Nseir S., Ader F., Marquette C.H., and Durocher A. Impact of fluoroquinolone use on multidrug-resistant bacteria emergence. Pathol Biol 53 8-9 (2005) 470-475
15. Mahamat A., Daurès J.P., and Sotto A. Evaluation of the relation between consumption of fluoroquinolones and emergence of resistance among Escherichia coli: contribution of observational and quasi-experimental studies. Med Mal Infect 35 11 (2005) 543-548
16. Talon D., Lallemand-De-Conto S., Thouverez M., and Bertrand X. Escherichia coli: resistance to quinolones and b-lactams of clinical strains isolated in the Franche-Comté region of France. Pathol Biol 52 2 (2004) 76-81
17. Tiemersma E.W., Bronzwaer S.L., Lyytikainen O., Degener J.E., Schrijnemakers P., Bruinsma N., et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 10 9 (2004) 1627-1634
18. Bloomfield S., Cookson B., Falkiner F., Griffith C., and Cleary V. Methicillin-resistant Staphylococcus aureus, Clostridium difficile, and extended-spectrum b-lactamase-producing Escherichia coli in the community: Assessing the problem and controlling the spread. Am J Infect Control 35 2 (2007) 86-88
19. Quentin C., Grobost F., Fischer I., Dutilh B., Brochet J.P., Jullin J., et al. Staphylococcus aureus in extrahospital practice: a 6-month period study in Aquitaine. Pathol Biol 49 1 (2001) 33-40
20. Bertrand X., Costa Y., and Pina P. Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003. Med Mal Infect 35 6 (2005) 329-334
21. Ficca G., Chauvel M., and de Moüy D. Prevalence of community-acquired methicillin-résistant Staphylococcus aureus. Les membres du réseau des biologistes de ville de l'AFORCOPI-BIO et les directeurs de laboratoire d'analyses médicales privés. Med Mal Infect 36 4 (2006) 207-212
22. Eveillard M., Lescure F.X., Eb F., and Schmit J.L. Carriage, acquisition, and transmission of methicillin-resistant Staphylococcus aureus in the community: consequences for prevention of cross-transmission and for antimicrobial therapy. Med Mal Infect 32 (2002) 717-724
23. Warshawsky B., Hussain Z., Gregson D.B., Alder R., Austin M., Bruckschwaiger D., et al. Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 21 11 (2000) 724-727
24. Salgado C.D., Farr B.M., and Calfee D.P. Community-Acquired Methicillin-Resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 36 2 (2003) 131-139
25. Skiest D.J., Brown K., Cooper T.W., Hoffman-Roberts H., Mussa H.R., and Elliott A.C. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalised patients. J Infect 54 5 (2007) 427-434
26. Lescure FX, Locher G, Eveillard M, Biendo M, Van Agt S, Le Loup G, et al. Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care. Infect Control Hosp Epidemiol 2006; 27(11):1213-8.